In a front-page story, the New York Times 
(5/17, A1, Kolata, Subscription Publication) reports that "a new study
that makes use of powerful databases of genetic information has found
that raising HDL" cholesterol "levels may not make any difference to
heart disease risk."
(5/17, A1, Kolata, Subscription Publication) reports that "a new study
that makes use of powerful databases of genetic information has found
that raising HDL" cholesterol "levels may not make any difference to
heart disease risk."
The Boston Globe
(5/17, A1, Johnson, Kotz) reports on its front page, "In the study
appearing in the medical journal The Lancet, a team led by researchers
from Massachusetts General Hospital and the Broad Institute examined the
health of more than 100,000 people, some of them with genetic
variations that elevated their levels of HDL." The researchers "found
that those variations did not protect against heart attacks."
(5/17, A1, Johnson, Kotz) reports on its front page, "In the study
appearing in the medical journal The Lancet, a team led by researchers
from Massachusetts General Hospital and the Broad Institute examined the
health of more than 100,000 people, some of them with genetic
variations that elevated their levels of HDL." The researchers "found
that those variations did not protect against heart attacks."
MedPage Today (5/17, Neale) reports, "In an accompanying editorial
, Steve Humphries, PhD, of University College London, and colleagues
noted that the study is consistent with previous mendelian randomization
analyses focused on the same issue and adds to an increasing number of
mendelian randomization studies of coronary heart disease biomarkers."
(5/17, Neale) reports, "In an accompanying editorial
, Steve Humphries, PhD, of University College London, and colleagues
noted that the study is consistent with previous mendelian randomization
analyses focused on the same issue and adds to an increasing number of
mendelian randomization studies of coronary heart disease biomarkers."
No comments:
Post a Comment